Digoxin: Clues to a Threshold for This Last-Resort Drug
Dr De Ferrari provides details on a substudy of the ARISTOTLE trial that examined digoxin blood...
12:01
Cost effects of risk-factor management in AF, apixaban costs vs warfarin, bioresorbable-scaffold...
10:12
Implications of Subclinical Leaflet Thrombosis in TAVR/SAVR
Dr Makkar provides more insights from the SAVORY and RESOLVE registries on the phenomenon of...
12:14
High-sensitivity troponin testing, dabigatran during AF ablation, valve-in-valve TAVR, Impella,...
09:49
Assessing Stroke Risk in Adult Congenital Heart Disease
Drs Lyle, Ammash, and McLeod discuss risk stratification for stroke in adults with complex...
18:49
2017 American College of Cardiology (ACC) sessions in review: PCSK9 inhibitors, bioresorbable...
09:06
FOURIER Presenter, Dr Marc Sabatine, Interviewed
Dr Mandrola gets the details on the PCSK9 inhibitor evolocumab, and asks the $64,000 (or is that...
13:33
Alt FOURIER: Diet and Exercise vs PCSK9i?
If Dr Walton-Shirley were designing the next trial on PCSK9 inhibitors, she'd include a...
07:36
FOURIER/EBBINGHAUS: So Far, So Good. But Can We Afford It?
Drs Harrington and Yancy review the efficacy and cognitive safety data for the PCSK9 inhibitor...
11:58
A post-PCI bleeding risk score, BMI and AF ablation, nonalcoholic fatty liver disease, sugary...
08:29
Statins poststroke, advance directives, sleep disorders and ICD shocks, genetic test to gauge...
11:01
The VA System: An Integrated Healthcare Example for All
The Veterans Health Administration is the largest integrated healthcare system in the US with a...
24:00
Should Cost of Therapy Be Considered in CV Guidelines?
New cardio drugs, such as PCSK9 inhibitors and the angiotensin receptor neprilysin inhibitor, are...
02:21
AF progression, alcohol and CV risk, embolic protection during TAVR, hydration to prevent...
12:29
Life and Times of Leading Cardiologists: Kim Eagle
When working as a fly fishing guide, Dr Eagle met the mentor who changed his life and paid for...
20:23
Cerebral microinfarcts, reduced-dose NOACs, quadpill for hypertension, and inappropriate ICD...
11:40
Bare-Metal, Drug-Eluting, and Bioresorbable Stents in Context
Drs Sandhu, Bell and Gulati discuss NORSTENT, LEADERS FREE, and the disappointing data on...
18:57
Calcium scores, NOAC usage, the Mediterranean diet, AF hospitalization outcomes, and waist-to-hip...
13:47
The Amount of Exercise Needed to Reduce All-Cause Mortality
Do exercise intensity and sport type affect mortality risk or is it all the same? Dr JoAnn Manson...
04:12
Mobility and BP, rivaroxaban for MACE prevention, alirocumab safety, brain injury after LV...
10:54
Lo último de Ciencia y naturaleza
Ep:110 In The Shadow Of Radium
Episodio
Chitin: The Alternative to Plastic
Episodio
Starkt skelett hela livet
Episodio
Premium
Plus